Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2007
11/15/2007US20070264262 Adrenoceptor beta 2-mediated diseases such as asthma and chronic obstructive pulmonary disease (COPD); N-(4-tert-butylbenzyl)-4-{[({3-[(2R)-2-(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino)propyl]phenyl}acetyl)amino]methy} benzamide
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007CA2657956A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/15/2007CA2650553A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854470A1 Method of treating inflammation disorders using extracts of passion fruit
11/14/2007EP1854469A1 Fermentation composition having immunomodulating effect
11/14/2007EP1853596A1 Novel, long-acting betamimetics for treating respiratory diseases
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853563A1 Salt of montelukast with tert.-butylamine
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1664058B1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
11/14/2007EP1317555B1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses
11/14/2007EP1296651B1 Method of making particles for use in a pharmaceutical composition
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007CN101072773A Pyrrole derivatives having CRTH2 receptor antagonist activity
11/14/2007CN101072752A Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
11/14/2007CN101072574A Sophorae subprostratae radix extract for prevention and treatment of respiratory diseases
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101070347A Bird-flu H5N1 novel mucous membrane immunization vaccine and its use
11/14/2007CN101070337A Tubeimuside and bile acid derivative and their medicine composition
11/14/2007CN101070323A Porphyrin derivative, its preparing method and use of same as small-molecular anti-oxidation agent
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/14/2007CN101069743A Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
11/14/2007CN101069714A Medicine for preventing and treating fowl's respiratory tract diseases and preparing method
11/14/2007CN101069706A Medicine for treating sinusitis
11/14/2007CN101069703A Medicine for treating acute, chronic pharyngitis, acute, chronic tonsillitis and preparing method
11/14/2007CN101069698A Method for preparing termite fugus gardens extract and use thereof
11/14/2007CN101069690A Doxycyline Hyclate lipid gels and preparing method
11/14/2007CN101069688A Medicine composition containing theocin-like medicines and vitamin K
11/14/2007CN101069555A Kudzuvine root areca and making method
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348258C Medicine for treating upper respiratory tract infection and its prepn
11/14/2007CN100348243C Preparation method of Chinese medicine for treating cough induced by cold and Chinese medicine prepared thereby
11/14/2007CN100348231C Medicine composition for resisting exogenous cold and high fever, and its preparing method
11/14/2007CN100348229C Capsule prepn for treating laryngopharyngitis and tonsillitis and its prepn process
11/14/2007CN100348217C Rhinological disease-treating pharmaceutical compositions and its preparing method
11/14/2007CN100348215C Kaihoujian drip pill for treating throat disease and its preparation method
11/14/2007CN100348210C Dandelion drip pill and its preparation method
11/14/2007CN100348188C Dripping pills of andrographolide and its preparing method
11/14/2007CN100348177C Two kinds of oral drip pills for treating tracheitis and its preparation method
11/14/2007CN100348174C Oral drop pill in use for clearing away heat and toxic material, relieving inflammation and alleviating pain, and preparation method
11/14/2007CN100348173C Drop pills of honeysuckle flower in use for clearing away heat and toxic materials and preparing method
11/14/2007CN100348171C Yujin drop pill for clearing away the heat-evil and expelling superficial evils and its preparation method
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2423288C New pharmaceutical compositions containing epinastine and pseudoephedrine
11/13/2007CA2285574C Method and composition for treating sleep apnea
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127297A2 Crystalline forms of a dimethylphenyl compound
11/08/2007WO2007127196A2 DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/08/2007WO2007126001A1 Antitussive or expectorant pharmaceutical composition comprising loxoprofen
11/08/2007WO2007125501A2 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
11/08/2007WO2007124849A2 Inhibitors of the task-1 and task-3 ion channel
11/08/2007WO2007124625A1 Limax polysaccharides, the production process and the use of the same
11/08/2007WO2007124594A1 Stem cells for treating lung diseases
11/08/2007WO2007105945A3 Use of non-digestable sacharides for giving an infant the best start after birth
11/08/2007WO2007103970A3 Compositions and methods for treating respiratory disorders
11/08/2007WO2007092095A3 [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
11/08/2007WO2007084868A3 Treatment of disorders by activation of the unfolded protein response
11/08/2007WO2007052023A3 Novel compounds
11/08/2007US20070259953 2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1alpha-hydroxyvitamin d3-26,23-lactone
11/08/2007US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007US20070259914 Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5.
11/08/2007US20070259909 Novel Difluoroethoxy-Substituted Hydroxy-6-Phenylphenanthridines and Their Use as Pde4 Inhibitors
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259873 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
11/08/2007US20070259868 phosphodiesterase PDE4 inhibitor; preparing claimed 3-(dialkoxy)phenyl-4-aminopyran intermediate from the claimed 4-oxo compound starting with hydrobromination of the corresponding phenylacetylene; antiinflammatory for airways and skin; respiratory; bronchodilator
11/08/2007US20070259855 Thiazolyl-dihydro-indazole
11/08/2007US20070259048 Mixture of micronized formoterol fumarate dihydrate salt (< 0.6 w/w) and a micronised pharmaceutically acceptable carrier/diluent, lactose; high storage stability such that the decomposition of formoterol will be < 2.0% (w/w) when stored in a powder device at 40 degrees C. and 75% relative humidity
11/08/2007US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258979 Interlukin receptor specific immunoglobulin for use in treatment and prevention of severe asthma, atopic dermatitis, fibrotic and chronic obstructive pulmonary diseases
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007US20070258971 Methods for Treating Local Tracheal, Bronchial or Alveolar Bleeding or Hemoptysis
11/08/2007US20070256685 Aerosol Formulations Comprising Formoterol Fumarate Dihydrate
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2705450A1 Stem cells for treating lung diseases
11/08/2007CA2650631A1 Crystalline forms of a dimethylphenyl compound
11/08/2007CA2650530A1 Dialkylphenyl compounds having .beta.2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/08/2007CA2650391A1 Inhibitors of the task-1 and task-3 ion channel
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 878